Biogen Responds to CADTH’s updated recommendation regarding coverage for SPINRAZA
Go back to Biogen Responds to CADTH’s updated recommendation regarding coverage for SPINRAZA| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 202.19 +1.57 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $200.62 | 52 Week High | $333.65 | |||
| Open | $202.24 | 52 Week Low | $223.02 | |||
| Day High | $203.30 | P/E | 25.89 | |||
| Day Low | $200.04 | EPS | $7.81 | |||
| Volume | 596,368 | |||||

